Does elevated prolactin cause hypogonadotropic hypogonadism with menstrual irregularity?

Hyperprolactinemia is a well-established cause of secondary hypogonadotropic hypogonadism, characterized by the disruption of the hypothalamic-pituitary-gonadal (HPG) axis. This condition occurs when elevated prolactin levels interfere with the neuroendocrine control of reproduction, leading to significant clinical manifestations in women, such as menstrual irregularities and estrogen deficiency.

Mechanistic basis of GnRH suppression

The suppression of gonadotropin-releasing hormone (GnRH) by prolactin is not a direct effect, as most GnRH neurons do not possess prolactin receptors. Instead, the mechanism involves an indirect pathway:

• Kisspeptin Inhibition: Prolactin binds to receptors (Prlrs) on kisspeptin-secreting neurons in the arcuate nucleus (the KNDy neuronal population). This activation triggers signaling pathways, such as pSTAT5, which inhibit the expression of Kiss1 mRNA.
• Reduced Pulse Frequency: Because kisspeptin is the primary excitatory driver of the GnRH pulse generator, its reduction significantly decreases the frequency and amplitude of GnRH pulses.
• Validation through Restoration: Human clinical evidence shows that administering exogenous kisspeptin to women with hyperprolactinemic amenorrhea can bypass the prolactin-induced block, successfully restoring LH pulsatility and reactivating the reproductive axis.

Clinical and effectiveness evidence

The disruption of the GnRH pulse generator leads to a cascade of endocrine effects that result in clinical hypogonadism:

• Lowered LH/FSH Signaling: The reduction in GnRH pulsatility directly inhibits the synthesis and secretion of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) from the anterior pituitary. Studies consistently show significantly lower mean LH and FSH levels in hyperprolactinemic women compared to healthy controls.
• Sex Steroid Deficiency: Reduced gonadotropin signaling impairs ovarian follicle maturation and suppresses the production of estradiol. This state of estrogen deficiency is a hallmark of the condition.
• Menstrual Dysregulation: The resulting hormonal imbalance leads to secondary amenorrhea, oligomenorrhea, and anovulation. Hyperprolactinemia is responsible for approximately 25% of all cases of secondary amenorrhea.

Clinical implications

The reproductive dysfunction associated with elevated prolactin is typically reversible. Normalizing prolactin levels—often through the use of dopamine agonists—restores kisspeptin and GnRH pulsatility. This restoration subsequently normalizes LH and FSH secretion, leading to the resumption of cyclic ovarian function and regular menstruation.

Bottom line

Elevated prolactin causes hypogonadotropic hypogonadism by inhibiting arcuate nucleus kisspeptin neurons, which suppresses GnRH pulsatility and lowers LH/FSH signaling. This leads to low sex steroids and menstrual irregularities, a process that is generally reversible with appropriate treatment to lower prolactin levels.